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all treatment approaches, was 5.2% (95% CI
5-5.5%), 3.9% (95% CI 3.4-4.4%) and 7.8%
(95% CI 7.2-8.5%) respectively. For patients
that underwent surgery, the 5-year survival
for patients with lesions in all locations, head,
body and tail was 18.8%, 15.9%, 23.8%
and 33.8% respectively. When analyzing
trends we noted a significant improvement in
survival for patients that underwent operative

intervention. Comparing the time periods
from 1977-1981 versus 2002-2006, the 5-year
survival for surgical patients improved for
all locations (9.2% to 22.6%, p<0.05) and
also for lesions in the head (8.3% to 19.3%,
p<0.05), body (6.7% to 26%, p<0.05) and tail
(14.7% to 40.7%, p<0.05).

patients with pancreatic cancer treated by
operative intervention. This improvement in
survival was more pronounced for patients
with primary lesions located in the body and
tail. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.044

Conclusion: The results of our study
demonstrate an improvement in survival for
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Background & Objectives: Esophageal
Cancer (EC) is a lethal malignancy with poor
prognosis and significant variations in the
incidence, mortality, and histopathology based
on geographic regions. The aim of this study
was to quantitatively analyze these variations
to identify patterns and areas for further
research.
Methods: We utilized the GLOBOCAN 2012,
and Cancer Incidence in five Continents,

Volume X (CI5X) database to analyze
variations in EC incidence and mortality.
Results: We found the EC incidence and
mortality is geographically varied with a
particularly high burden in East Asia and
Eastern/Southern Africa where esophageal
squamous cell carcinoma (SCC) predominates
over adenocarcinoma (AC). Interestingly,
there is a dichotomy between the high
incidence of esophageal SCC in East Africa
and low incidence in West Africa. The global
incidence and mortality from EC is expected
to rise in the coming decades. Asia, and

China in particular, will continue to be the
areas most burdened by EC, while Africa
is expected to surpass the incidence and
mortality rates of Europe.
Conclusions: The global burden of EC
is expected to rise in the coming years.
Understanding the geographic, environmental,
and genetic contributors to the development
of EC will be essential in combating its
prevalence. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.045
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Background & Objectives: Intragastric
balloon placement is an approved weightloss procedure with a lower BMI cutoff than
bariatric surgery. The objective of this study
was to examine the frequency and outcomes
of balloon placements in 2016.
Methods: The MBSAQIP database was
analyzed for adults who underwent elective,
endoscopic intragastric balloon placement.
Emergent cases, patients with previous foregut
surgery and those unable to be followed for
30 days were excluded. Comparisons were
made between placements performed by GI

and surgery. Analysis performed using SPSS
v25.0, α=.05.
Results: Our study included 445 patients.
Majority were female (80%) and Caucasian
(90.6%). Median age and BMI were 49.0
(IQR 15.4) and 35.7 (IQR 6.46), respectively.
Prevalence of medically treated hypertension
was 30.8%, hyperlipidemia 18.9%, GERD
20.4%, and diabetes 12.6% (insulin and
non-insulin dependent). Mean operative
time was 15.48 ± 9.89 minutes. No 30-day
mortalities were reported. 70 balloons were
placed by GI and 375 by surgery. There was a
significantly higher rate of readmission for GI
7.1% vs 1.9% surgery (p=.027). No significant
difference was seen for rates of post-operative

dehydration (GI: 7.1% vs surgery: 7.2%;
p=1.000), emergency room encounters (GI:
14.0% vs surgery: 4.0%; p=.486), 30-day
reoperations (GI: 0.0% vs surgery: 0.8%;
p=1.000), and 30-day reinterventions (GI:
5.7% vs surgery 2.4%; p=.132).
Conclusions: The majority of patients
undergoing intragastric balloon placement
fall within obesity class 1 or 2 and have low
rates of comorbidities. The procedure can be
performed by gastroenterology or surgery at
bariatric centers with similar outcomes. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.046
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Introduction: Noncompressible truncal
hemorrhage and brain injury account for most
early mortality in military personnel on the
battlefield. Currently there is no effective
treatment for noncompressible truncal
hemorrhage, other than rapid evacuation to
a surgical facility. We intended to develop a
porcine model of noncompressible truncal

hemorrhage so that we might be able to
develop new treatments for this clinical
problem.
Methods: Swine (boars, 3 months, 32-34 kg)
underwent one of three injury types: 1) central
stellate injury, just anterior to suprahepatic
inferior vena cava (N=6); 2) excision of a
portal vein branch distal to the main trunk
(N=5); or 3) near-transection of the left lateral
lobe (LLL) of the liver at its base, which
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cut the hepatic and portal veins to this lobe
(N=12). The midline incision was towel
clipped immediately after injury, and animals
were monitored for 60 min or until death.
Resuscitation was performed with warm LR
(max volume = 100 mL/kg), with a target
MAP set at 80% of pre-injury MAP.
Results: The starting weight, MAP,
hemoglobin, arterial pH, INR, and pre-injury
blood loss did not differ among groups (p
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> 0.05, ANOVA). Postmortem evaluation
revealed that 2-3 hepatic veins were
transected by injury type 1, 1-2 portal vein
branches plus 1 hepatic vein were transected
by injury type 3 (LLL transection).
Conclusions: The hemorrhage severity of the
central stellate injury was inadequate, while
hemorrhage from excision of a proximal
branch of the portal vein appeared to be too
severe (i.e., the subjects died too quickly).

Near-transection of the hepatic LLL at its base
appeared to yield hemorrhage of appropriate
severity, as indicated by the 40% 1-hour
mortality and intermediate values for MAP,
blood loss, and other variables. Our plan is to
use this latter injury model in the development
of therapies for noncompressible truncal
hemorrhage. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.047
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Background: The use of exogenous
testosterone has become more prevalent in
recent years but the effects of such use in
regards to potential cerebrovascular disease
have yet to come to a conclusion. In this case
report, we discuss a patient who suffered
an ischemic stroke due to testosterone
supplementation.
Case presentation: A middle-aged
patient with history of hypertension and
hyperlipidemia that presented with falls,

difficulty performing simple tasks and slurred
speech. Patient had been taking testosterone
injections every 6 months for the prior 2 years
for loss of energy and reported low levels.
Lab work revealed a hemoglobin of 20 g/dL
and a hematocrit of 51.5%. MRI of the brain
showed a left striatocapsular ischemic infarct.
He was given the diagnosis of ischemic stroke
due to polycythemia and thrombus formation
secondary to testosterone supplementation.

association with ischemic stroke and there
may be an optimal level that is safe.
Conclusion: The risk of ischemic stroke may
be related to testosterone and DHT levels but
no clear guidelines exist on optimal levels
in supplementation. Thus, clinicians should
be aware of the potential risk and monitor
androgen and hematocrit levels. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.048

Discussion: Testosterone and
dihydrotestosterone (DHT) has both
protective and adverse effects. Both low and
high levels of testosterone and DHT have an
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Objective: To assess the effectiveness of
treatment for status epilepticus (SE) at UNMC
and determine patient health outcomes related
to the delayed control of seizures
Design/Methods: Retrospective chart
review was performed on 1565 adult
patients who underwent continuous video
electroencephalography (cvEEG) for
suspected seizures between January 1, 2012
and February 28, 2018.
Results: 49 patients had and were treated for
64 incidences of convulsive or nonconvulsive

SE recorded on cvEEG or clinical seizures
longer than 5 min which were documented by
a neurologist. Among 64 cases, 55 incidences
required the second AED treatment, and
40 out of 55 cases were treated with the
third AED subsequently. The mean seizure
detection-to-needle time for the first,
second, and third antiepileptic drugs were
167, 239, and 297 minutes, respectively.
Benzodiazepines were administered as the
first AED in only 46 % of all treated cases.
The duration of the hospital stays in patients
treated with the first AED within 60 min after
seizure detection was shorter compared to
those whose treatment was delayed (23.0 vs.

33.6 days, p=0.41). The mortality rate in the
former group was lower than that in the group
which did not receive AEDs within 60 min
(28.6 vs. 53.6%, p=0.02).
Conclusion: The current treatment approaches
for SE at UNMC are inefficient with
significant delay in delivery of medications
after seizure detection; they may contribute
to the prolonged hospital stay and increased
mortality. In order to improve patient care, the
existing protocol for the treatment of SE at
UNMC must be revised. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.049
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Background: VNS Therapy has demonstrated
overall cost savings in patients with drug-

51

resistant epilepsy. The overall goal of this
project is to evaluate the clinical and cost
effectiveness of the Aspire SR 106 VNS
(Vagus Nerve Stimulator) system, using
retrospective patient data. We anticipate
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the extra dimension of closed-loop
autostimulation in the Aspire 106 model will
demonstrate more efficient utilization of
health care resources.
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